Heparin response issues - Video 1
Antithrombin deficiency is the most common cause of low heparin response7,9
Heparin response issues - Video 1 Transcript
- Hi. I'm Dr. Stephen Bader, a cardiac anesthesiologist in a busy community hospital, but I used to work in a large, academic, university hospital.
- Obviously, during an operative procedure, we need to balance the risk of bleeding with that of thromboembolic events for each individual patient.
- My experience using heparin for various procedures is that it can be very unpredictable.
Whether I'm doing a vascular surgery with an interventional radiologist or a cardiac surgery that requires large doses of heparin, it is important not only to prevent clotting and other thromboembolic complications during the procedure but also to not have significant bleeding at the end of the procedure.
- Heparin resistance, or responsiveness issues, can occur in heparin-requiring surgeries, and it is a problem that some may be worried about and uncomfortable dealing with should it arise because administering additional heparin to overcome resistance could lead to bleeding at the end of the procedure.
- So let's take a few minutes to talk about how heparin works, how we deal with heparin response issues, and how we might consider them before they are encountered during a procedure.
What is low heparin response?
- While there isn't a consistent definition, low heparin response is commonly defined as needing a daily dose in excess of 35,000 units/day.
- As we'll talk about a bit later, low heparin response is often caused by antithrombin deficiency.
- Antithrombin is a thromboprotective protein that inhibits the coagulation enzymes in a slow, progressive manner when heparin is absent. These enzymes include factor Xa and thrombin, and to a lesser extent, factors IXa, XIa, XIIa, and VIIa.
- However, when heparin is present, the action of antithrombin is enhanced by at least 1000-fold.
- Thus, antithrombin plays a key role in anticoagulation by preventing the activation of coagulation-promoting proteins except at the site of injury.
- In this way, antithrombin participates in a feedback loop in which blood can clot rapidly when needed but does not clot all of the time.
- Now, let's talk about the interaction between antithrombin and heparin.
- Heparin exerts its anticoagulant effects based on its interaction with the cofactor antithrombin. Heparin and antithrombin work together to provide a continuous anticoagulant effect.
- This allows antithrombin, which is a relatively slow inhibitor of the anticoagulation cascade, to become a more potent anticoagulant.
- Now that we know a little more about how antithrombin and heparin work, how does heparin response affect what we do before, during, and after surgery?
Before a procedure, I consider a patient's risk of bleeding, including:
- The invasiveness of the surgery
- The consequences of bleeding
- The patient's medical history, with special attention to comorbidities that may have an impact on hemostasis or coagulation.
- I may notice that the patient has other risk factors, such as being elderly or having illnesses such as renal diseases or a history of bleeding or anemia.
- If I see that a patient has been receiving heparin therapy for a few days prior to the surgery, in the back of my mind, I'm already considering whether the patient will respond to heparin as expected and I'm anticipating the ACT as well as PTT levels.
During the procedure, I'm reacting to the patient's response to heparin and titrating to effect—giving heparin, checking ACT levels, and titrating heparin based on that response.
- When I suspect low heparin response, the options to diagnose it in the operating room are limited, but I utilize interventions aimed at achieving the targeted ACT and providing an adequate buffer of safety for anticoagulation.
- Most of the time, we give another dose of heparin. If a patient doesn't respond, I may think about antithrombin deficiency, which can be either acquired or hereditary. Antithrombin deficiency is the most common cause of low heparin response, and as you know, there are various ways to replenish antithrombin.
- Other mechanisms affecting heparin response are less common than antithrombin deficiency, such as increased heparin clearance, high factor VIII levels, and dosing or administration errors. Some patients may have underlying thrombocytosis, causing neutralization of heparin.
- After the surgery, physicians may consider hematologic workup to make sure that a patient with low heparin response doesn't have hereditary antithrombin deficiency, which is rare but puts patients at high risk of thrombosis. These patients need to be identified for appropriate management postoperatively and during future surgeries and life events, such as childbirth, which further increase their risk of thrombosis.
- For these patients, the risks of hereditary antithrombin deficiency can be mitigated with functional evaluation of antithrombin activity, including laboratory testing, as well as with long-term management to address and reduce risks during future procedures or other high-risk life events.
Heparin response issues - Section 2
Dr. Stephen Bader discusses important considerations for before, during, and after surgery
- Heparin resistance, or responsiveness issues, can occur in heparin-requiring surgeries, and administering additional heparin to overcome resistance could lead to bleeding at the end of the procedure
- Low heparin response is commonly defined as needing a daily dose in excess of 35,000 units/day
- Options to diagnose low heparin response in the operating room are limited, but interventions should be utilized to achieve the targeted ACT
- After the surgery, physicians may consider hematologic workup to make sure that a patient with low heparin response does not have hereditary antithrombin deficiency
- Patients with hereditary antithrombin deficiency need to be identified for appropriate management postoperatively and during future surgeries and life events, such as childbirth, which further increase their risk of thrombosis
Heparin response issues - Section 3
Mitigating VTE Risk: Functional Evaluation of AT
- The risks of hereditary antithrombin deficiency can be mitigated with functional evaluation of antithrombin activity, including laboratory testing, as well as with long-term management to address and reduce risks during future procedures or other high-risk life events5
Whom to Test12
How to Test: Functional Antithrombin Assays
The effect of drugs that use antithrombin to exert their anticoagulation may be altered when THROMBATE III is added or withdrawn. Regularly perform coagulation tests suitable for the anticoagulant used (eg, aPTT and anti-Factor Xa activity) to avoid excessive or insufficient anticoagulation. Additionally, monitor the patients for the occurrence of bleeding or thrombosis.
Eopl - Title
Learn more about:
Eopl - Link 4
CONVENIENCE: THROMBATE III delivers trusted therapy
Eopl - Link 3
THROMBATE III REDUCES VTE RISK: Dr. Bader talks about surgery in patients with hATd
Eopl - Link 5
THROMBATE III TOOLS AND RESOURCES: Downloadable resources, and much more